Target Name: OLIG1
NCBI ID: G116448
Review Report on OLIG1 Target / Biomarker Content of Review Report on OLIG1 Target / Biomarker
OLIG1
Other Name(s): BHLHE21 | Class B basic helix-loop-helix protein 6 | Basic domain, helix-loop-helix protein, class B, 6 | bHLHe21 | basic domain, helix-loop-helix protein, class B, 6 | oligodendrocyte transcription factor 1 | bHLHb6 | OTTHUMP00000199731 | Oligodendrocyte-specific bHLH transcription factor 1 | oligodendrocyte-specific bHLH transcription factor 1 | Class E basic helix-loop-helix protein 21 | class B basic helix-loop-helix protein 6 | OTTHUMP00000067600 | BHLHB6 | Oligodendrocyte lineage transcription factor 1 | Oligodendrocyte transcription factor 1 | oligodendrocyte lineage transcription factor 1 | OLIG1_HUMAN | class E basic helix-loop-helix protein 21 | oligo1 | Oligo1

OLIG1: A Protein Involved in Cell Apoptosis, Proliferation and Inflammation

OLIG1 (BHLHE21) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the BHLHE family, which includes several similar proteins that are involved in the regulation of cellular processes such as cell growth, apoptosis, and inflammation.

OLIG1 has been identified as a potential drug target in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its role in these conditions is not well understood, but its involvement in the regulation of cellular processes suggests that it may play a significant role in the development and progression of these diseases.

One of the key functions of OLIG1 is its role in the regulation of cell apoptosis, which is the process by which cells die when they have reached the end of their life. OLIG1 has been shown to play a role in the regulation of apoptosis in various tissues, including the brain. Studies have shown that OLIG1 is involved in the clearance of damaged or dysfunctional cells, and that its absence may contribute to the development of neurodegenerative diseases such as Alzheimer's disease.

Another function of OLIG1 is its role in the regulation of cell proliferation. OLIG1 has been shown to play a role in the regulation of cell proliferation in various tissues, including the brain. Studies have shown that OLIG1 is involved in the control of cell proliferation and that its levels are regulated in response to various factors, including growth factors and chemical signals.

OLIG1 has also been shown to be involved in the regulation of inflammation. OLIG1 is a key regulator of the production of pro-inflammatory cytokines, which are involved in the regulation of immune responses and inflammation. Studies have shown that OLIG1 plays a role in the regulation of inflammation in various tissues, including the brain.

In conclusion, OLIG1 is a protein that is involved in a variety of cellular processes that are important for the development and progression of various diseases. Its role in the regulation of cell apoptosis, proliferation, and inflammation suggests that it may be a valuable drug target for the treatment of these conditions. Further research is needed to fully understand the role of OLIG1 in these processes and to develop effective treatments for these diseases.

Protein Name: Oligodendrocyte Transcription Factor 1

Functions: Promotes formation and maturation of oligodendrocytes, especially within the brain. Cooperates with OLIG2 to establish the pMN domain of the embryonic neural tube (By similarity)

The "OLIG1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OLIG1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OLIG2 | OLIG3 | Oligosaccharyltransferase complex | OLMALINC | OLR1 | OMA1 | OMD | OMG | OMP | Oncostatin-M Receptor | ONECUT1 | ONECUT2 | ONECUT3 | OOEP | OOSP1 | OOSP2 | OPA1 | OPA1-AS1 | OPA3 | OPALIN | OPCML | OPHN1 | Opioid receptor | OPLAH | OPN1LW | OPN1MW | OPN1MW3 | OPN1SW | OPN3 | OPN4 | OPN5 | OPRD1 | OPRK1 | OPRL1 | OPRM1 | OPRPN | OPTC | OPTN | OR10A2 | OR10A3 | OR10A4 | OR10A5 | OR10A6 | OR10A7 | OR10AA1P | OR10AB1P | OR10AC1 | OR10AD1 | OR10AF1P | OR10AG1 | OR10AK1P | OR10C1 | OR10D1P | OR10D3 | OR10D4P | OR10G2 | OR10G3 | OR10G4 | OR10G7 | OR10G8 | OR10G9 | OR10H1 | OR10H2 | OR10H3 | OR10H4 | OR10H5 | OR10J1 | OR10J2P | OR10J3 | OR10J5 | OR10K1 | OR10K2 | OR10P1 | OR10Q1 | OR10R2 | OR10S1 | OR10T2 | OR10V1 | OR10W1 | OR10X1 | OR10Z1 | OR11A1 | OR11G2 | OR11H1 | OR11H12 | OR11H13P | OR11H2 | OR11H5P | OR11H6 | OR11H7 | OR11J2P | OR11J5P | OR11K2P | OR11L1 | OR11M1P | OR12D2 | OR12D3 | OR13A1 | OR13C2 | OR13C3